Identification of Extremely Rare Pathogenic CNVs by Array CGH in Saudi Children with Developmental Delay, Congenital Malformations, and Intellectual Disability
暂无分享,去创建一个
Sajjad Karim | Z. Mirza | A. Chaudhary | I. R. Hussein | M. Al-Qahtani | S. Alsaedi | Hans-Juergen Schulten
[1] I. Mills,et al. Spatially resolved clonal copy number alterations in benign and malignant tissue , 2022, Nature.
[2] C. V. van Asperen,et al. Recommendations for reporting results of diagnostic genomic testing , 2022, European Journal of Human Genetics.
[3] S. Hassan,et al. Consanguinity and Congenital Heart Disease Susceptibility: Insights into Rare Genetic Variations in Saudi Arabia , 2022, Genes.
[4] Bernat Gel,et al. Evaluation of CNV detection tools for NGS panel data in genetic diagnostics , 2020, European Journal of Human Genetics.
[5] J. Merrick,et al. A clinical primer on intellectual disability , 2020, Translational pediatrics.
[6] S. South,et al. Technical standards for the interpretation and reporting of constitutional copy number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) , 2019, Genetics in Medicine.
[7] T. Liehr,et al. DNA Copy Number Variations as Markers of Mutagenic Impact , 2019, International journal of molecular sciences.
[8] Le Zhang,et al. Correction: Comprehensively benchmarking applications for detecting copy number variation , 2019, PLoS Comput. Biol..
[9] Chih-ping Chen,et al. Array-CGH increased the diagnostic rate of developmental delay or intellectual disability in Taiwan. , 2019, Pediatrics and neonatology.
[10] Peter Natesan Pushparaj,et al. Array comparative genomic hybridization based identification of key genetic alterations at 2p21-p16.3 (MSH2, MSH6, EPCAM), 3p23-p14.2 (MLH1), 7p22.1 (PMS2) and 1p34.1-p33 (MUTYH) regions in hereditary non polyposis colorectal cancer (Lynch syndrome) in the Kingdom of Saudi Arabia , 2019, Saudi journal of biological sciences.
[11] Le Zhang,et al. Comprehensively benchmarking applications for detecting copy number variation , 2019, PLoS Comput. Biol..
[12] Steven P. Miller,et al. Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. , 2019, Neurology.
[13] K. Sullivan. Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome , 2019, Immunological reviews.
[14] Peter Natesan Pushparaj,et al. Genomic amplification of chromosome 7 in the Doxorubicin resistant K562 cell line , 2018, Bioinformation.
[15] M. Yasir,et al. Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH) , 2018, PloS one.
[16] A. Chaudhary,et al. Identification of De Novo and Rare Inherited Copy Number Variants in Children with Syndromic Congenital Heart Defects , 2018, Pediatric Cardiology.
[17] M. Assidi,et al. Use of Array Comparative Genomic Hybridization for the Diagnosis of DiGeorge Syndrome in Saudi Arabian Population , 2018, Cytogenetic and Genome Research.
[18] Biren M. Dave,et al. OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome , 2018, American journal of human genetics.
[19] R. Hennekam,et al. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement , 2018, Nature Reviews Endocrinology.
[20] Peter Natesan Pushparaj,et al. Chromosomal Micro-aberration in a Saudi Family with Juvenile Myoclonic Epilepsy. , 2017, CNS & neurological disorders drug targets.
[21] E. McCann,et al. Current evidence-based recommendations on investigating children with global developmental delay , 2017, Archives of Disease in Childhood.
[22] Sajjad Karim,et al. Genomic answers for recurrent spontaneous abortion in Saudi Arabia: An array comparative genomic hybridization approach. , 2017, Reproductive biology.
[23] Bradley P. Coe,et al. Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases , 2017, Nature Genetics.
[24] D. Pilz,et al. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals. , 2017, European journal of medical genetics.
[25] A. Chaudhary,et al. Genome wide array-CGH and qPCR analysis for the identification of genome defects in Williams’ syndrome patients in Saudi Arabia , 2016, Molecular Cytogenetics.
[26] C. Powell,et al. Survival of children with trisomy 13 and trisomy 18: A multi‐state population‐based study , 2016, American journal of medical genetics. Part A.
[27] S. Mattson,et al. Jacobsen syndrome: Advances in our knowledge of phenotype and genotype , 2015, American journal of medical genetics. Part C, Seminars in medical genetics.
[28] M. Adam,et al. Evaluation and diagnosis of the dysmorphic infant. , 2015, Clinics in perinatology.
[29] E. Guillén-Navarro,et al. Clinical comparison of 10q26 overlapping deletions: Delineating the critical region for urogenital anomalies , 2015, American journal of medical genetics. Part A.
[30] M. I. Melaragno,et al. Duplication 9p and their implication to phenotype , 2014, BMC Medical Genetics.
[31] M. Waldenberger,et al. Compound heterozygosity of low-frequency promoter deletions and rare loss-of-function mutations in TXNL4A causes Burn-McKeown syndrome. , 2014, American journal of human genetics.
[32] E. Goldmuntz,et al. 22q11.2 Deletion syndrome is associated with increased perioperative events and more complicated postoperative course in infants undergoing infant operative correction of truncus arteriosus communis or interrupted aortic arch. , 2014, The Journal of thoracic and cardiovascular surgery.
[33] J. Moeschler,et al. Comprehensive Evaluation of the Child With Intellectual Disability or Global Developmental Delays , 2014, Pediatrics.
[34] M. Ninan,et al. Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide , 2014, Case reports in oncological medicine.
[35] David T. Miller,et al. Chromosomal microarray impacts clinical management , 2014, Clinical genetics.
[36] N. Brown,et al. Characterization of core clinical phenotypes associated with recurrent proximal 15q25.2 microdeletions , 2014, American journal of medical genetics. Part A.
[37] Sang-Jin Park,et al. The clinical application of array CGH for the detection of chromosomal defects in 20,126 unselected newborns , 2013, Molecular Cytogenetics.
[38] Yu-ping Wang,et al. Comparative Studies of Copy Number Variation Detection Methods for Next-Generation Sequencing Technologies , 2013, PloS one.
[39] M. Tzetis,et al. Array comparative genomic hybridization as a clinical diagnostic tool in syndromic and nonsyndromic congenital heart disease , 2013, Pediatric Research.
[40] P. Stankiewicz,et al. Comparison of chromosome analysis and chromosomal microarray analysis: what is the value of chromosome analysis in today’s genomic array era? , 2012, Genetics in Medicine.
[41] Marc S. Williams,et al. Clinical Utility of Chromosomal Microarray Analysis , 2012, Pediatrics.
[42] B. Rodríguez-Santiago,et al. Contribution of Rare Copy Number Variants to Isolated Human Malformations , 2012, PloS one.
[43] Bradley P. Coe,et al. Genome structural variation discovery and genotyping , 2011, Nature Reviews Genetics.
[44] D. Ledbetter,et al. Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability , 2010, Journal of Medical Genetics.
[45] Leslie G Biesecker,et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.
[46] Tomas W. Fitzgerald,et al. Origins and functional impact of copy number variation in the human genome , 2010, Nature.
[47] A. Rauch,et al. Comprehensive genotype–phenotype analysis in 230 patients with tetralogy of Fallot , 2009, Journal of Medical Genetics.
[48] P. Stankiewicz,et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size , 2009, Journal of Medical Genetics.
[49] Frank Speleman,et al. Challenges for CNV interpretation in clinical molecular karyotyping: lessons learned from a 1001 sample experience. , 2009, European journal of medical genetics.
[50] N. de Leeuw,et al. An 8.35 Mb overlapping interstitial deletion of 8q24 in two patients with coloboma, congenital heart defect, limb abnormalities, psychomotor retardation and convulsions. , 2009, European journal of medical genetics.
[51] U. Pannicke,et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II , 2009, Nature Genetics.
[52] P. Stankiewicz,et al. Clinical and molecular‐cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an ∼5 Mb deletion del(11)(q24.3) , 2008, American journal of medical genetics. Part A.
[53] D. Hernandez,et al. A duplication at chromosome 11q12.2–11q12.3 is associated with spinocerebellar ataxia type 20 , 2008, Human molecular genetics.
[54] J. D. den Dunnen,et al. Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification. , 2008, The Journal of clinical endocrinology and metabolism.
[55] N. Fida,et al. A prospective study of congenital malformations among live born neonates at a University Hospital in Western Saudi Arabia. , 2007, Saudi medical journal.
[56] N. Niikawa,et al. CHMP4B, a novel gene for autosomal dominant cataracts linked to chromosome 20q. , 2007, American journal of human genetics.
[57] N. Carter. Methods and strategies for analyzing copy number variation using DNA microarrays , 2007, Nature Genetics.
[58] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[59] A. Dutra,et al. Core binding factor beta (CBFB) haploinsufficiency due to an interstitial deletion at 16q21q22 resulting in delayed cranial ossification, cleft palate, congenital heart anomalies, and feeding difficulties but favorable outcome , 2006, American journal of medical genetics. Part A.
[60] Y. Fukushima,et al. Large fontanelles are a shared feature of haploinsufficiency of RUNX2 and its co‐activator CBFB , 2004, Congenital anomalies.
[61] M A Whelen,et al. Practice parameter: Evaluation of the child with global developmental delay , 2003, Neurology.
[62] S. Minoshima,et al. Role of TBX1 in human del22q11.2 syndrome , 2003, The Lancet.
[63] M. Gingold,et al. CME Practice parameter : Evaluation of the child with global developmental delay , 2003 .